Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View

ORCID
0000-0003-0768-5789
Zugehörigkeit
Institute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Centre Mainz, 55131 Mainz, Germany
Taylor, Katherine J.;
Zugehörigkeit
Department of Oncology, Oslo University Hospital, 0372 Oslo, Norway
Amdal, Cecilie D.;
ORCID
0000-0002-1914-494X
Zugehörigkeit
Research Support Service, Oslo University Hospital 0372 Oslo, Norway
Bjordal, Kristin;
Zugehörigkeit
Department of Oncology, Oslo University Hospital, 0372 Oslo, Norway
Astrup, Guro L.;
Zugehörigkeit
Faculty of Dentistry, University of Oslo, 0455 Oslo, Norway
Herlofson, Bente B.;
Zugehörigkeit
Department of Radiotherapy-Oncology, Faculty of Medicine and Health Sciences—Human Structure and Repair, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium
Duprez, Fréderic;
ORCID
0000-0003-4406-8958
Zugehörigkeit
Department of Head and Neck Surgery, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil
Gama, Ricardo R.;
ORCID
0000-0002-6353-2202
Zugehörigkeit
Department of Radiation Oncology, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil
Jacinto, Alexandre;
Zugehörigkeit
Department of Otorhinolaryngology-Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden
Hammerlid, Eva;
ORCID
0000-0002-0112-9215
Zugehörigkeit
Department of Radiation Oncology, Ospedale dell’Angelo, 30174 Venice, Italy
Scricciolo, Melissa;
Zugehörigkeit
Department Otolaryngology-Head and Neck Surgery, Amsterdam UMC Location Vrije Universiteit, De Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands
Jansen, Femke;
Zugehörigkeit
Department Otolaryngology-Head and Neck Surgery, Amsterdam UMC Location Vrije Universiteit, De Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands
Verdonck-de Leeuw, Irma M.;
ORCID
0000-0002-9677-3176
Zugehörigkeit
Division of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy
Fanetti, Giuseppe;
GND
1078441464
ORCID
0000-0001-9671-0784
Zugehörigkeit
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany
Guntinas-Lichius, Orlando;
GND
1097299880
ORCID
0000-0003-4613-2810
Zugehörigkeit
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany
Inhestern, Johanna;
Zugehörigkeit
Head and Neck Unit, Department of Radiation Oncology, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium
Dragan, Tatiana;
Zugehörigkeit
Department of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
Fabian, Alexander;
ORCID
0000-0001-9511-9167
Zugehörigkeit
Department of Otorhinolaryngology, St. Georg Hospital, 04129 Leipzig, Germany
Boehm, Andreas;
ORCID
0009-0004-6594-1044
Zugehörigkeit
Department of Otorhinolaryngology, St. Georg Hospital, 04129 Leipzig, Germany
Wöhner, Ulrike;
ORCID
0000-0001-8021-6116
Zugehörigkeit
Cancer Center, Kobe University Hospital, Kobe 650-0017, Japan
Kiyota, Naomi;
Zugehörigkeit
Department of Oral and Maxillofacial Surgery—Plastic Surgery, University Medical Centre Mainz, 55131 Mainz, Germany
Krüger, Maximilian;
ORCID
0000-0001-8999-5208
Zugehörigkeit
Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
Bonomo, Pierluigi;
ORCID
0000-0002-0823-4907
Zugehörigkeit
Rehabilitation Medicine Unit, Strategic Health Services Department, Istituto Nazionale Tumori—IRCCS—Fondazione G. Pascale, 80131 Naples, Italy
Pinto, Monica;
ORCID
0000-0002-5540-4796
Zugehörigkeit
Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, 3000 Leuven, Belgium
Nuyts, Sandra;
ORCID
0000-0002-3934-9950
Zugehörigkeit
Department of Otolaryngology, Head and Neck Surgery, Instituto Português de Oncologia Francisco Gentil do Porto, 4200-072 Porto, Portugal
Silva, Joaquim C.;
Zugehörigkeit
Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany
Stromberger, Carmen;
Zugehörigkeit
Department of Radiation Oncology, Azienda Sanitaria Locale, 72100 Brindisi, Italy
Tramacere, Francesco;
Zugehörigkeit
Department of Otorhinolaryngology, University Hospital Gießen und Marburg, 35392 Giessen, Germany
Bushnak, Ayman;
Zugehörigkeit
Department of Otorhinolaryngology—Head and Neck Surgery, “S. Chiara” Hospital, Azienda Provinciale per i Servizi Sanitari (APSS), 38122 Trento, Italy
Perotti, Pietro;
Zugehörigkeit
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany
Plath, Michaela;
ORCID
0000-0002-1621-2142
Zugehörigkeit
Department of Otorhinolaryngology—Head and Neck Surgery, ASST Spedali Civili of Brescia, University of Brescia, 25123 Brescia, Italy
Paderno, Alberto;
Zugehörigkeit
Oral Medicine Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel
Stempler, Noa;
ORCID
0000-0002-0009-4911
Zugehörigkeit
Dental Oncology Unit, Department of Oral Medicine and Pathology and Hospital Dentistry, Dental School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Kouri, Maria;
ORCID
0000-0001-5784-7964
Zugehörigkeit
Institute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Centre Mainz, 55131 Mainz, Germany
Singer, Susanne

The long-term problems of head and neck cancer survivors (HNCS) are not well known. In a cross-sectional international study aimed at exploring the long-term quality of life in this population, 1114 HNCS were asked to state their two most serious long-term effects. A clinician recorded the responses during face-to-face appointments. A list of 15 example problems was provided, but a free text field was also available. A total of 1033 survivors responded to the question. The most frequent problems were ‘dry mouth’ (DM) ( n = 476; 46%), ‘difficulty swallowing/eating’ (DSE) ( n = 408; 40%), ‘hoarseness/difficulty speaking’ (HDS) ( n = 169; 16%), and ‘pain in the head and neck’ (PHN) ( n = 142; 14%). A total of 5% reported no problems. Logistic regression adjusted for age, gender, treatment, and tumor stage and site showed increased odds of reporting DM and DSE for chemo-radiotherapy (CRT) alone compared to surgery alone (odds ratio (OR): 4.7, 95% confidence interval (CI): 2.5–9.0; OR: 2.1, CI: 1.1–3.9), but decreased odds for HDS and PHN (OR: 0.3, CI: 0.1–0.6; OR: 0.2, CI: 0.1–0.5). Survivors with UICC stage IV at diagnosis compared to stage I had increased odds of reporting HDS (OR: 1.9, CI: 1.2–3.0). Laryngeal cancer survivors had reduced odds compared to oropharynx cancer survivors of reporting DM (OR: 0.4, CI: 0.3–0.6) but increased odds of HDS (OR: 7.2, CI: 4.3–12.3). This study provides evidence of the serious long-term problems among HNCS.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: © 2023 by the authors.

Nutzung und Vervielfältigung: